Responsible Marketing
Supporting the SDGs Goals
Stakeholders Directly Impacted
Goals and Performance Highlights
Commitment, Challenge and Opportunity
Since the products of the group are related to user health, in addition to producing quality, safe, and standardized products, providing accurate information about the products is considered a high priority responsibility. The group will not provide false, misleading, exaggerated advertisements or use messaging, audio, or images that mislead customers about gender, religion, race, disabilities, or personal relationships that could cause confusion about the quality, quantity, price, or reference products of other manufacturers.
Management and Operational Approach
The group has studied the legal requirements for advertising both online and offline, and regularly trains employees on these laws every month. The group also reviews product information for pharmacy customers, hospitals, and consumers to ensure correct product usage and addresses complaints regarding product quality.
The group provides useful product information tailored to customer needs and behavior to assist in decision-making through marketing activities, and does not engage in deceptive practices or promote false information about products. Advertising materials, including labels for pharmaceuticals, herbal products, dietary supplements, and medical devices, are distributed to the public with correct details. The group also promotes product knowledge and manufacturing standards for all employees through internal or external projects or activities.
The group’s communication and public relations efforts control the dissemination of media and advertising strictly, adhering primarily to the regulations set by the Food and Drug Administration (FDA)
In cases where third parties, such as customers, use media for advertising, which the group cannot control, if such actions are found, the company has measures in place to educate customers. The company does not encourage or hire customers to engage in exaggerated advertising. Before customers distribute products, the group informs them about advertising guidelines, specifying that only media prepared by the company should be used, as it has been authorized by the FDA. For products that do not require FDA approval for advertising, the company carefully screens the content and advertising media before delivering them to customers, ensuring they comply with relevant standards and regulations
In marketing and advertising, the group regularly trains sales staff each month, focusing on product knowledge and keeping information up to date about the pharmaceutical industry. This enhances the expertise of the sales staff in providing accurate and current information to pharmacy and hospital customers, elevating product-related communications.
The group places high importance on conducting business ethically and transparently, particularly in the sale of medicines and medical products, which directly impact consumers’ health. The group is committed to strictly following ethical standards and relevant laws. Our company is a member of the Thai Pharmaceutical Manufacturers Association (TPMA), which oversees ethical practices in drug promotion in Thailand. The association plays a crucial role in setting practices and regulations aligned with international standards to ensure that our employees have accurate knowledge and understanding of the Pharmaceutical Sale Act and related laws and regulations. The company participates in training programs organized by the TPMA covering topics such as:
Employees who participate in training must pass tests based on the association’s standards and will receive a certificate as evidence of their readiness and ability to operate in accordance with ethical principles.
In addition to employee training, our company also promotes a corporate culture focused on honesty and business ethics through the following actions:
- Internal meetings to review ethical principles and required standards
- Appointing representatives from the company, trained by the association, to transmit knowledge and practices to employees within the organization
The company is committed to continuously monitoring and evaluating ethical practices in drug sales, tracking employee exam results, and providing further guidance when necessary to ensure that our company can maintain ethical standards and credibility in the pharmaceutical industry sustainably.
The group has communication channels through social media to help consumers understand the products. Additionally, there are plans to participate in academic seminars, set up product booths in hospitals, and attend exhibitions related to both modern pharmaceutical products and herbal products to further enhance consumer knowledge and understanding of the products.
Additionally, the group participates in various academic events and fitness venues to provide information to product users, answer questions, and clarify doubts. For example, at CPHI South East Asia 2024, a representative from the group shared information on using Phlaiwana for office syndrome symptoms, and in November, Bangkok Drug Co., Ltd. (BDC) organized a seminar on “Innovation in Synbiotics and Superfoods” to exchange knowledge and create understanding about gut balance. The event also featured booths with information about other products from the group.
